Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepa® (icosapent ethyl) is Amarin's first FDA approved product and is available in the United States by prescription. For more information about Vascepa visit www.vascepa.com.
|Quote at:||Fri, 21 Oct 2016 16:00:00|
|(20 minute delayed share price)|
This website, amarincorp.com and the product websites, Vascepa.com, Vascepasavings.com & LowerMyTrigs.com, are the only company sanctioned websites pertaining to the Amarin group of companies or its product, Vascepa® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for false or misleading materials contained on other non-Amarin controlled websites or other social media sites.